지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제17권 제4호
- 발행연도
- 2016.1
- 수록면
- 1,637 - 1,641 (5page)
이용수
초록· 키워드
오류제보하기
Oxaliplatin, a third generation novel platinum compound is the most effective first line chemotherapeutic agent for colorectal cancer (CRC) in combination with 5FU and leucovorin. It is indicated for pancreatic, gastric and testicular cancers combined with bevacuzimab, capecitabine, irinotecan and other cytotoxic agents. However, moderate to severe hypersensitivity reactions (HSR) during or after oxaliplatin infusion usually require cessation of chemotherapy or substitution of the key therapeutic drug which largely interferes with improved patient prognosis. This mini- review showcases recent and accepted opinions/approaches in oxaliplatin induced HSR management. Physicians and oncologists have varying attitudes regarding the decision to rechallenge the patient after an HSR experience, efficacy of desensitization protocols, effectiveness and selection of drugs for premedication and possibilities of cross sensitivity to other platinum agents (e.g. carboplatin). A brief insight into underlying molecular mechanisms and clinical manifestations of oxaliplatin induced HSR is offered. We have also discussed the management of oxaliplatin induced HSR and risk stratification for a successful and complete chemotherapeutic plan.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Effects of Analgecine on Oxaliplatin-Induced Neurotoxicity in Patients with Gastrointestinal Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
Cancer Research and Treatment
2015 .01
-
Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis
대한외과학회 학술대회 초록집
2022 .11
-
Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
Yonsei Medical Journal
2021 .01
-
조영제 과민반응 관리의 실제: 국내 일개 대학병원 원내 관리지침 소개
Allergy Asthma & Respiratory Diseases
2023 .01
-
Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
Gut and Liver
2017 .01
-
Effects of Oxaliplatin on Phosphatidylserine Externalization in Erythrocytes: Implications for Prothrombotic Activity and Erythrophagocytosis
환경독성보건학회 심포지엄 및 학술대회
2023 .11
-
Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
Annals of Dermatology
2019 .01
-
의료기관의 사회적 책임활동(HSR)이 조직건강성과 고객지향성에 미치는 영향
보건의료산업학회지
2019 .01
-
Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer
Annals of Surgical Treatment and Research
2018 .04
-
5-HT1A receptors mediate the analgesic effect of rosavin in a mouse model of oxaliplatin-induced peripheral neuropathic pain
The Korean Journal of Physiology & Pharmacology
2021 .09
-
Effect of Cell Pentrating Peptide(CPP)-Oxaliplatin Conjugate on The Treatment of Colorectal Cancer
대한외과학회 학술대회 초록집
2020 .11
-
대장암 복막전이의 분자적 분석
대한의사협회지
2022 .09
-
Apurinic/apyrimidinic endonuclease 1 is associated with poor prognosis after curative resection followed by adjuvant chemotherapy in patients with stage III colon cancer
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2022 .06
-
Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media
Allergy, Asthma & Immunology Research
2022 .07
-
Rituximab 지연성과민반응에 대한 신속 탈감작 적용 1예
Allergy Asthma & Respiratory Diseases
2019 .01
-
A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation
Journal of Gastric Cancer
2023 .04
-
약물과민반응 환자에서 탈감작요법 적용
Allergy Asthma & Respiratory Diseases
2023 .04
-
Oxaliplatin, 5-Fluorouracil and Leucovorin (FOLFOX-4) as First Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer
Asian Pacific journal of cancer prevention : APJCP
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0